Andrew Geall

Scientific Advisory Board Member

Andrew Geall is vice president of formulations, analytics and chemistry at Avidity Biosciences, where over the past four years he has helped pioneer the development of the company’s antibody-oligonucleotide conjugate delivery platform. He has over 20 years of professional experience in the development of drug delivery systems and is acknowledged...

Roles at Verve Therapeutics

  • Scientific Advisory Board Member

    Current role

  • Scientific Advisor

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.